在暴露前预防中对囊向抗逆转录病毒药物的考虑
William M McFadden1, Mia Faerch2, Karen A Kirby1
1Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA 30322, USA; Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Trends in molecular medicine
|February 28, 2025
概括
莱纳卡帕维尔 (LEN) 通过在病毒集成之前向HIV-1囊体,对艾滋病毒暴露前预防 (PrEP) 有希望. 临床试验表明它在预防HIV-1感染方面具有潜在的有效性.
科学领域:
- 病毒学 病毒学
- 传染性疾病 传染性疾病
- 药物开发 药物开发
背景情况:
- 抗逆转录病毒疗法 (ART) 抑制了艾滋病毒复制在艾滋病毒感染者 (PLWH).
- 暴露前预防 (PrEP) 需要在整合前或整合期间阻止HIV复制,以便在未感染个体中有效预防.
研究的目的:
- 讨论lenacapavir (LEN) 作为潜在的PrEP药物的临床研究.
- 探索临床前囊结合性抗病毒药物对于预防艾滋病毒的适用性.
- 通过向囊细胞来解决预防HIV-1感染的关键问题.
主要方法:
- 对莱纳卡帕维尔 (LEN) 临床研究的综述.
- 对于PrEP应用的临床前囊结合性抗病毒药物的理论评估.
- 讨论开发囊向性艾滋病毒预防策略的关键因素.
主要成果:
- 列纳卡帕维尔 (LEN) 是第一类抗逆转录病毒药物,在整合之前强烈向HIV-1囊蛋白 (CA).
- 在正在进行的PURPOSE试验中,LEN已经证明了高保护效率.
结论:
- 莱纳卡帕维尔 (LEN) 是一种有前途的PrEP方法,针对HIV-1囊.
- 对囊向抗病毒药物的进一步研究是必要的,以开发新的艾滋病毒预防策略.
相关概念视频
Retrovirus Life Cycles
45.5K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.5K
Retroviruses
12.2K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
12.2K


